↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

1,322 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (11c)pe2i   -   -   -   -   1件:
6 
 2   (2-chloro-5-[11c]methoxy-n-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)   -   -   -   -   1件:
6 
 3   (3beta, 5beta, 25r)-spirostan-3-ol   -   -   -   -   1件:
6 
 4   (3ß, 5ß, 25r)-spirostan-3-ol   -   -   -   -   1件:
6 
 5   (6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol   -   -   -   -   1件:
6 
 6   (r)-troloxamide quinone   -   -   -   -   1件:
6 
 7   (s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol   -   -   -   -   1件:
6 
 8   (s)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate   -   -   -   -   1件:
6 
 9   0 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 10   0.3 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 11   0.9% sodium chloride   Sodium chloride   D02056   -   -   3件:
6,
14,
51 
 12   0.9% sodium chloride (normal saline)   Sodium chloride   D02056   -   -   1件:
6 
 13   009-0   -   -   -   -   1件:
6 
 14   009-1   -   -   -   -   1件:
6 
 15   009-2   -   -   -   -   1件:
6 
 16   009-3   -   -   -   -   1件:
6 
 17   009-4   -   -   -   -   1件:
6 
 18   009-5   -   -   -   -   1件:
6 
 19   009-a0   -   -   -   -   1件:
6 
 20   009-a1   -   -   -   -   1件:
6 
 21   009-a2   -   -   -   -   1件:
6 
 22   009-a3   -   -   -   -   1件:
6 
 23   1 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 24   1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 25   1 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 26   1. tesofensine (ns 2330)   Tesofensine   -   -   -   1件:
6 
 27   1.0 mg rasagiline mesylate   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 28   11c-pbr28   -   -   -   -   1件:
6 
 29   11c-raclopride   Raclopride   -   -   -   1件:
6 
 30   15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 31   15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 32   15o h2o   -   -   -   -   1件:
6 
 33   18-fdtbz   -   -   -   -   1件:
6 
 34   18f florbetaben   -   -   -   -   1件:
6 
 35   18f- dtbz   -   -   -   -   1件:
6 
 36   18f-av-133   Florbenazine f-18   -   -   -   1件:
6 
 37   18f-av-45   -   -   -   -   2件:
6,
127 
 38   18f-dopa   -   -   -   -   2件:
6,
75 
 39   18f-dopa pet   -   -   -   -   1件:
6 
 40   18f-dtbz   -   -   -   -   1件:
6 
 41   18f-dtbz av-133   -   -   -   -   1件:
6 
 42   18f-fdg   Fludeoxyglucose f-18   -   -   -   7件:
6,
13,
46,
53,
84,
127,
300 
 43   1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-   -   -   -   -   1件:
6 
 44   1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea   -   -   -   -   1件:
6 
 45   1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-   -   -   -   -   1件:
6 
 46   1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea   -   -   -   -   1件:
6 
 47   2 mg perampanel   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
6 
 48   200 mg bia 6-512   -   -   -   -   1件:
6 
 49   207-3120   -   -   -   -   1件:
6 
 50   240mg amantadine hcl er tablets   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 51   25330   -   -   -   -   1件:
6 
 52   3 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 53   3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 54   3 mg tropicamide   Tropicamide   D00397   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 55   3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate   -   -   -   -   1件:
6 
 56   320mg amantadine hcl er tablets   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 57   4 mg perampanel   Perampanel   D08964   4件: GRIA1, GRIA2, GRIA3, GRIA4   13件: Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   1件:
6 
 58   6abeta - apomorphine-10,11-diol hydrochloride hemihydrate   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 59   6aß - apomorphine-10,11-diol hydrochloride hemihydrate   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 60   7 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 61   7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)   Tavapadon   D11431   2件: DRD1, DRD5   10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   1件:
6 
 62   7-beta-hydroxyepiandrosterone   -   -   -   -   1件:
6 
 63   [11c]pbr28   -   -   -   -   1件:
6 
 64   [11c]pxt012253   -   -   -   -   1件:
6 
 65   [11c]smw139   -   -   -   -   1件:
6 
 66   [123i] 5-ia   -   -   -   -   1件:
6 
 67   [123i] ibvm and spect imaging   -   -   -   -   1件:
6 
 68   [123i] mzint injection and serial dynamic spect imaging   -   -   -   -   1件:
6 
 69   [123i]-ibvm   -   -   -   -   1件:
6 
 70   [123i]b-cit   -   -   -   -   1件:
6 
 71   [123i]b-cit spect imaging   -   -   -   -   1件:
6 
 72   [123i]beta cit   -   -   -   -   1件:
6 
 73   [123i]beta cit and spect imaging   -   -   -   -   1件:
6 
 74   [123i]beta-cit   -   -   -   -   1件:
6 
 75   [123i]beta-cit and spect imaging   -   -   -   -   1件:
6 
 76   [123i]clinde   -   -   -   -   2件:
6,
13 
 77   [123i]mni-420   -   -   -   -   2件:
6,
8 
 78   [123i]ß cit   -   -   -   -   1件:
6 
 79   [123i]ß cit and spect imaging   -   -   -   -   1件:
6 
 80   [123i]ß-cit   -   -   -   -   1件:
6 
 81   [123i]ß-cit and spect imaging   -   -   -   -   1件:
6 
 82   [14c]-bia 9-1067   -   -   -   -   1件:
6 
 83   [15o]h2o   -   -   -   -   1件:
6 
 84   [18f] cfpypb   -   -   -   -   1件:
6 
 85   [18f] lbt-999 pet   -   -   -   -   1件:
6 
 86   [18f] pbr06   -   -   -   -   2件:
6,
13 
 87   [18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane   -   -   -   -   1件:
6 
 88   [18f]-feppa   -   -   -   -   2件:
6,
13 
 89   [18f]dpa-714 pet scan   -   -   -   -   1件:
6 
 90   [18f]fdopa pet/ct   -   -   -   -   1件:
6 
 91   [18f]fe-pe2i   -   -   -   -   1件:
6 
 92   [18f]fpeb   -   -   -   -   3件:
6,
8,
206 
 93   [18f]mk-9470   -   -   -   -   1件:
6 
 94   [18f]mni-1126   -   -   -   -   1件:
6 
 95   [18f]mppf   -   -   -   -   1件:
6 
 96   [18f]nos   -   -   -   -   1件:
6 
 97   [18f]p17-059   -   -   -   -   1件:
6 
 98   [18f]t807 ([18f]mni-777)   -   -   -   -   2件:
5,
6 
 99   Ab1010   Masitinib   D10229   1件: KIT   11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   6件:
2,
5,
6,
13,
46,
96 
 100   Abbv-0805   -   -   -   -   1件:
6 
 101   Abbv-951   -   -   -   -   1件:
6 
 102   Abt-slv187   -   -   -   -   1件:
6 
 103   Acamprosate   Acamprosate   D02780, D07058   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   2件:
6,
206 
 104   Accordion pill carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 105   Accordion pill™ carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 106   Accordion pill™ carbidopa/levodopa 50/400 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 107   Accordion pill™ carbidopa/levodopa 50/500 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 108   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 109   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 110   Acp-103   -   -   -   -   1件:
6 
 111   Acr325   Acr325   -   -   -   1件:
6 
 112   Active comparator   -   -   -   -   2件:
6,
46 
 113   Active drug (biib014) at 10, 30, 100, or 300 mg once daily.   Dihydrotachysterol   D00299   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
6 
 114   Active drug: pimavanserin 17mg (2 strength tablets)   Pimavanserin   -   -   -   1件:
6 
 115   Active investigational treatment ent-01   -   -   -   -   1件:
6 
 116   Ad-810n (zonisamide)   Zonisamide   D00538   8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   1件:
6 
 117   Adjuvant without active component   -   -   -   -   2件:
6,
17 
 118   Administration of stable isotope-labelled leucine-   L-leucine   D00030   -   -   1件:
6 
 119   Ads-5102   -   -   -   -   2件:
6,
13 
 120   Ads-5102 (extended release amantadine hcl)   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 121   Adx48621   -   -   -   -   1件:
6 
 122   Affitope® pd01a   -   -   -   -   1件:
6 
 123   Affitope® pd01a + adjuvant   -   -   -   -   2件:
6,
17 
 124   Afq056   -   -   -   -   3件:
6,
8,
206 
 125   Afq056 with l-dopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 126   Agomelatine   Agomelatine   D02578   3件: HTR2C, MTNR1A, MTNR1B   6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6 
 127   Agomelatine or piacebo   Agomelatine   D02578   3件: HTR2C, MTNR1A, MTNR1B   6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   1件:
6 
 128   Allogeneic bone marrow-derived mscs   -   -   -   -   1件:
6 
 129   Allopurinol   Allopurinol   D00224   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97 
 130   Altropane   Altropane   -   -   -   1件:
6 
 131   Altropane®   -   -   -   -   1件:
6 
 132   Amantadine   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   4件:
6,
8,
13,
127 
 133   Amantadine 300 mg   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 134   Amantadine hcl er   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 135   Amantadine hcl extended release   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 136   Amantadine hydrochloride   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 137   Amantadine sulfate   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
6 
 138   Ambrosan 60mg tablets   -   -   -   -   1件:
6 
 139   Ambroxol   Ambroxol   D07442   -   -   2件:
6,
19 
 140   Ambroxol hydrochloride   Ambroxol   D07442   -   -   1件:
6 
 141   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 142   Ampyra first,   -   -   -   -   1件:
6 
 143   Anavex2-73   -   -   -   -   2件:
6,
156 
 144   Anti-parkinson medication   -   -   -   -   4件:
5,
6,
7,
17 
 145   Ap-cd/ld   -   -   -   -   1件:
6 
 146   Ap09004   -   -   -   -   1件:
6 
 147   Apl-130277   -   -   -   -   1件:
6 
 148   Aplindore   Aplindore   -   -   -   1件:
6 
 149   Aplindore mr tablets   Aplindore   -   -   -   1件:
6 
 150   Apo-go   -   -   -   -   1件:
6 
 151   Apo-go®   -   -   -   -   1件:
6 
 152   Apokinon   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 153   Apokyn   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 154   Apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 155   Apomorphine 0.25% (2.5mg/ml)   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 156   Apomorphine hcl injection   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 157   Apomorphine hydrochloride   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 158   Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 159   Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 160   Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 161   Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 162   Apomorphine hydrocloride   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 163   Apomorphine hydrocloride hemihydrate   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 164   Apomorphine infusion   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 165   Apomorphine nasal powder   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 166   Aqw051   -   -   -   -   1件:
6 
 167   Aricept   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
6,
13,
78,
124 
 168   Aricept 5 mg-filmtabletten   -   -   -   -   1件:
6 
 169   Aricept 5mg-filmtabletten   -   -   -   -   1件:
6 
 170   Aripiprazole   Aripiprazole   D01164   4件: DRD2, DRD3, HTR1A, HTR2A   12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   2件:
6,
206 
 171   Armodafinil   Armodafinil   D03215   1件: SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   3件:
6,
13,
84 
 172   At 10   Dihydrotachysterol   D00299   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
6 
 173   Atm fog in pd   -   -   -   -   1件:
6 
 174   Atomoxetine   Atomoxetine   D02574, D07473   1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13 
 175   Atypical antipsychotics   -   -   -   -   1件:
6 
 176   Autologous mesenchymal stem cells   -   -   -   -   5件:
2,
6,
13,
17,
46 
 177   Av-101   -   -   -   -   1件:
6 
 178   Avalox   Moxifloxacin   D00874, D08237   -   -   1件:
6 
 179   Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al   Moxifloxacin   D00874, D08237   -   -   1件:
6 
 180   Ave8112   -   -   -   -   1件:
6 
 181   Avp-923   -   -   -   -   3件:
2,
6,
13 
 182   Avp-923-45   -   -   -   -   1件:
6 
 183   Azd3241   -   -   -   -   2件:
6,
17 
 184   Azd3241 300 mg bid   -   -   -   -   1件:
6 
 185   Azd3241 600 mg bid   -   -   -   -   1件:
6 
 186   Azd3241 alternative titration scheme with formulation 1 or 2   -   -   -   -   1件:
6 
 187   Azd3241 er formulation 1   -   -   -   -   1件:
6 
 188   Azd3241 extended release tablets 100 mg   -   -   -   -   1件:
6 
 189   Azd3241 extended release tablets 25 mg   -   -   -   -   1件:
6 
 190   Azilect   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
5,
6,
17 
 191   Azilect®   -   -   -   -   1件:
6 
 192   B-cit and spect imaging   -   -   -   -   1件:
6 
 193   B6, b12, l-methylfolate   Levomefolic acid   D09353   -   -   1件:
6 
 194   Balance   Isoxaflutole   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299 
 195   Bavisant   Bavisant   D09870   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 196   Bavisant dihydrochloride monohydrate   Bavisant   D09870   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 197   Bavisant hydrochloride monohydrate   Bavisant   D09870   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 198   Bee venom   -   -   -   -   1件:
6 
 199   Ben-2001   -   -   -   -   1件:
6 
 200   Benserazide   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 201   Benserazide hydrochloride   Benserazide   D03082   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 202   Benzofuran   Benzofuran   -   -   -   1件:
6 
 203   Best medical treatment   -   -   -   -   1件:
6 
 204   Bf 2.649   -   -   -   -   1件:
6 
 205   Bf2.649   -   -   -   -   1件:
6 
 206   Bf2.649 (pitolisant)   Pitolisant   D10749   1件: HRH3   1件: Neuroactive ligand-receptor interaction   1件:
6 
 207   Bi-sifrol®   -   -   -   -   1件:
6 
 208   Bia 3-202   -   -   -   -   1件:
6 
 209   Bia 3-202 (200 mg)   -   -   -   -   1件:
6 
 210   Bia 6-512   -   -   -   -   1件:
6 
 211   Bia 6-512 100 mg   -   -   -   -   1件:
6 
 212   Bia 6-512 100 mg dose   -   -   -   -   1件:
6 
 213   Bia 6-512 200 mg dose   -   -   -   -   1件:
6 
 214   Bia 6-512 25 mg   -   -   -   -   1件:
6 
 215   Bia 6-512 25 mg dose   -   -   -   -   1件:
6 
 216   Bia 6-512 400 mg   -   -   -   -   1件:
6 
 217   Bia 6-512 50 mg dose   -   -   -   -   1件:
6 
 218   Bia 9-1067   -   -   -   -   1件:
6 
 219   Bia 9-1067 (test)   -   -   -   -   1件:
6 
 220   Bia 9-1067 15 mg   -   -   -   -   1件:
6 
 221   Bia 9-1067 25 mg   -   -   -   -   1件:
6 
 222   Bia 9-1067 30 mg   -   -   -   -   1件:
6 
 223   Bia 9-1067 5 mg   -   -   -   -   1件:
6 
 224   Bia 9-1067 micronized   -   -   -   -   1件:
6 
 225   Bia 9-1067 non-micronized   -   -   -   -   1件:
6 
 226   Biib014   -   -   -   -   1件:
6 
 227   Biib054   -   -   -   -   1件:
6 
 228   Biib094   -   -   -   -   1件:
6 
 229   Bisphosphonates   -   -   -   -   2件:
6,
274 
 230   Bone marrow derived mesenchymal stem cells   -   -   -   -   2件:
6,
60 
 231   Bont-a   -   -   -   -   1件:
6 
 232   Botox   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   4件:
6,
13,
149,
226 
 233   Botulinum toxin   -   -   -   -   1件:
6 
 234   Botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 235   Botulinum toxin type b   Botulinum toxin type b   D02735   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   3件:
2,
6,
51 
 236   Botulinum toxin type b (myobloc)   Botulinum toxin type b   D02735   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   2件:
2,
6 
 237   Botulinum toxin: xeomin   -   -   -   -   1件:
6 
 238   Bromocriptine   Bromocriptine   D00780, D03165   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
74 
 239   Bromocriptine and other dopamine agonists   Bromocriptine   D00780, D03165   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 240   Btrx-246040   -   -   -   -   1件:
6 
 241   Btx-a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
6 
 242   Bumetanide   Bumetanide   D00247   1件: SLC12A2   3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection   2件:
6,
158 
 243   Bumetanide white, oblong, scored tablet   Bumetanide   D00247   1件: SLC12A2   3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection   1件:
6 
 244   Bupleurum+ginkgo   Ginkgo biloba   -   -   -   1件:
6 
 245   Buspirone   Buspirone   D00702, D07593   2件: DRD2, HTR1A   10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   2件:
6,
51 
 246   Buspirone hydrochloride   Buspirone   D00702, D07593   2件: DRD2, HTR1A   10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   1件:
6 
 247   Butylphthalide   Butylphthalide   -   -   -   2件:
2,
6 
 248   Byetta 5 micrograms   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 249   Cabaseril   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 250   Cabaseril, 1,0 mg tablette   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 251   Cabaseril, 2,0 mg tablette   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 252   Cabergoline   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   3件:
6,
74,
75 
 253   Caffeine   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
2,
6,
46,
78,
96,
97 
 254   Caffeine 100-200 mg bid   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 255   Caffeine alkaloid   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 256   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 257   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 258   Cannabis   Medical cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 259   Cannabis oil   Medical cannabis   -   -   -   1件:
6 
 260   Cannabis, medical   Medical cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 261   Capsaicin   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226 
 262   Capsaicin vapor   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
6 
 263   Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 264   Capture   Bifenthrin   -   -   -   2件:
6,
46 
 265   Carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   8件:
2,
4,
6,
13,
17,
90,
164,
201 
 266   Carbidopa 20 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 267   Carbidopa 27.5 mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 268   Carbidopa 65 mg capsule   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 269   Carbidopa and levodopa 25mg/100mg   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 270   Carbidopa fu   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 271   Carbidopa levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 272   Carbidopa monohydrate   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 273   Carbidopa, levodopa, entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 274   Carbidopa- levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 275   Carbidopa-levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
2,
4,
6 
 276   Carbidopa/l-dopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 277   Carbidopa/l-dopa/entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 278   Carbidopa/levodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 279   Carbidopa/levodopa, immediate release   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 280   Carbidopa/levodopa/entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 281   Carbon   Activated charcoal   D03251   -   -   7件:
6,
46,
85,
86,
96,
97,
298 
 282   Carnosine   Carnosine   -   -   -   2件:
6,
13 
 283   Carnosine supplementation   Carnosine   -   -   -   1件:
6 
 284   Carvedilol   Carvedilol   D00255, D03415   5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
6,
57,
86,
113 
 285   Catapres ampoules   Clonidine   D00281, D00604   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
6 
 286   Cd-ld cr   -   -   -   -   1件:
6 
 287   Cd-ld ir   -   -   -   -   1件:
6 
 288   Cdnf   -   -   -   -   1件:
6 
 289   Ceftriaxone   Ceftriaxone   D00924, D07659   -   -   3件:
2,
6,
97 
 290   Cep-1347   -   -   -   -   1件:
6 
 291   Cep-1347 10mg   -   -   -   -   1件:
6 
 292   Cep-1347 50mg   -   -   -   -   1件:
6 
 293   Cep1347   Cep1347   -   -   -   1件:
6 
 294   Cep1347 25mg   Cep1347   -   -   -   1件:
6 
 295   Cere-120   -   -   -   -   1件:
6 
 296   Cere-120: adeno-associated virus delivery of neurturin   -   -   -   -   1件:
6 
 297   Cerebral dopamine neurotrophic factor   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 298   Ceretec   Technetium tc-99m exametazime   D02284   -   -   1件:
6 
 299   Ceretec (tm) estabilizado   Technetium tc-99m exametazime   D02284   -   -   1件:
6 
 300   Champix   Varenicline   D08669   2件: CHRNA4, CHRNB2   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   1件:
6 
 301   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 302   Chocolate   Cocoa   -   -   -   1件:
6 
 303   Cipralex   -   -   -   -   1件:
6 
 304   Cjh1 (clr4001)   -   -   -   -   1件:
6 
 305   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 306   Clarium   Loratadine   D00364   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
6 
 307   Clarium 50 mg retardtabletten   Loratadine   D00364   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   1件:
6 
 308   Clartihromycin, amoxicillin, and omeprazole   Amoxicillin   D00229, D02925, D07452   -   -   1件:
6 
 309   Clonazepam   Clonazepam   D00280   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 310   Clonidine   Clonidine   D00281, D00604   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
6,
78 
 311   Clonidine hydrochloride   Clonidine   D00281, D00604   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   2件:
6,
78 
 312   Clozapine   Clozapine   D00283   11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E   8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway   1件:
6 
 313   Cocoa   Cocoa   -   -   -   1件:
6 
 314   Coenzyme q10   Ubidecarenone   D01065   -   -   10件:
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 315   Coenzyme q10 nanodispersion (nanoquinone)   Ubidecarenone   D01065   -   -   1件:
6 
 316   Coenzyme q10 with vitamin e   Vitamin e   D02331   -   -   1件:
6 
 317   Cogane™ (pym50028)   -   -   -   -   1件:
6 
 318   Cohort 1:nilotinib oral capsules (150mg or 300mg)   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
6 
 319   Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1)   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
6 
 320   Combination injection of epo and g-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
6 
 321   Comparator: carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 322   Comparator: levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 323   Comtan   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 324   Comtan®   -   -   -   -   1件:
6 
 325   Comtess   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 326   Comtess®   -   -   -   -   1件:
6 
 327   Continuous intrajejunal infusion of levodopa-carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 328   Continuous release dopamine agonists   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 329   Control   Chloroxylenol   D03473   -   -   4件:
6,
13,
46,
168 
 330   Controlled-release levodopa / carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 331   Coq10   Ubidecarenone   D01065   -   -   3件:
5,
6,
8 
 332   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 333   Cu(ii)atsm   -   -   -   -   2件:
2,
6 
 334   Cvd00118-e   -   -   -   -   1件:
6 
 335   Cvt-301   -   -   -   -   1件:
6 
 336   Cvt-301 (dose level 1)   -   -   -   -   1件:
6 
 337   Cvt-301 (dose level 2)   -   -   -   -   1件:
6 
 338   Cvt-301 35mg   -   -   -   -   1件:
6 
 339   Cvt-301 50mg   -   -   -   -   1件:
6 
 340   Cvt-301 high dose   -   -   -   -   1件:
6 
 341   Cvt-301 low dose   -   -   -   -   1件:
6 
 342   Cvt-301, lip   -   -   -   -   1件:
6 
 343   Cvxl-0107   -   -   -   -   1件:
6 
 344   Cx-8998   -   -   -   -   1件:
6 
 345   Cyberknife   -   -   -   -   1件:
6 
 346   Cymbalta   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49 
 347   Cysteine   L-cysteine   D00026, D02326   -   -   9件:
6,
13,
19,
84,
85,
88,
90,
254,
296 
 348   Cystoscopic injection of botox into the urinary bladder   -   -   -   -   1件:
6 
 349   D-serine   Serine   D00016   -   -   1件:
6 
 350   D-serine (~2g/day)   Serine   D00016   -   -   1件:
6 
 351   Da-9701   -   -   -   -   1件:
6 
 352   Da-9805 45mg   -   -   -   -   1件:
6 
 353   Da-9805 90mg   -   -   -   -   1件:
6 
 354   Dacepton 5 mg/ml   -   -   -   -   1件:
6 
 355   Dacepton 5 mg/ml infuusioneste, liuos   -   -   -   -   1件:
6 
 356   Darifenacin   Darifenacin   D01699, D03654   1件: CHRM3   9件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   2件:
6,
13 
 357   Dark chocolate (85% cocoa)   Cocoa   -   -   -   1件:
6 
 358   Date   Date   -   -   -   3件:
6,
88,
113 
 359   Datscan   Ioflupane i-123   D10014   -   -   3件:
2,
5,
6 
 360   Datscan™   -   -   -   -   1件:
6 
 361   Dc158am   -   -   -   -   1件:
6 
 362   Deanol   Deanol   D07777   -   -   1件:
6 
 363   Deanol pyroglutamate   Deanol   D07777   -   -   1件:
6 
 364   Debrumyl   -   -   -   -   1件:
6 
 365   Deferiprone   Deferiprone   D07416   -   -   5件:
2,
6,
120,
122,
233 
 366   Deferiprone (ferriprox)   Deferiprone   D07416   -   -   1件:
6 
 367   Deferiprone 600 mg delayed release tablet   Deferiprone   D07416   -   -   1件:
6 
 368   Desmopressin   Desmopressin   D00291, D02235   2件: AVPR2, F8   4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   5件:
6,
64,
72,
225,
288 
 369   Desmopressin acetat   Desmopressin   D00291, D02235   2件: AVPR2, F8   4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   1件:
6 
 370   Desmotabs   -   -   -   -   1件:
6 
 371   Desmotabs® 0,2 mg tabletten   -   -   -   -   1件:
6 
 372   Desmotabs® 0,2mg tabletten   -   -   -   -   1件:
6 
 373   Dexdor   -   -   -   -   4件:
2,
4,
6,
70 
 374   Dexmedetomidina   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
6 
 375   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 376   Dexmedetomidine hydrochloride infusion   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
6 
 377   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 378   Different diets   -   -   -   -   1件:
6 
 379   Dihydroergotoxine mesylate   Ergoloid mesylate   D02268   6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
6 
 380   Dipivefrin   Dipivefrin   D02349   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 381   Dipivefrine   Dipivefrin   D02349   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 382   Dipraglurant   Dipraglurant   -   -   -   1件:
6 
 383   Ditropan elixir   Oxybutynin   D00465, D00722   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 384   Dm-1992   -   -   -   -   1件:
6 
 385   Dnl151 high dose   -   -   -   -   1件:
6 
 386   Dnl151 low dose   -   -   -   -   1件:
6 
 387   Dnl201 high dose   -   -   -   -   1件:
6 
 388   Dnl201 low dose   -   -   -   -   1件:
6 
 389   Dns-7801 (high dose)   -   -   -   -   1件:
6 
 390   Dns-7801 (low-dose)   -   -   -   -   1件:
6 
 391   Docosahexaenoic acid   Doconexent   -   -   -   7件:
6,
49,
90,
94,
240,
299,
301 
 392   Docosahexaenoic acid (dha)   Doconexent   -   -   -   3件:
6,
94,
299 
 393   Domperidone   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   5件:
6,
13,
17,
51,
230 
 394   Domperidone (drug)   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 395   Dompéridone   -   -   -   -   1件:
6 
 396   Donepezil   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   9件:
5,
6,
13,
46,
78,
124,
127,
156,
206 
 397   Donepezil sandoz   Donepezil   D00670, D07869   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 398   Dopamine   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   3件:
6,
7,
74 
 399   Dopamine agent   Dopamine   D00633, D07870   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 400   Dopamine agonists (pramipexole, ropirinole)   Pramipexole   D00559, D05575   3件: DRD2, DRD3, DRD4   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 401   Dopaminergic agonist + apomorphine   Apomorphine   D02004, D07460   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
6 
 402   Dopaminergic agonists   -   -   -   -   1件:
6 
 403   Dops   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
6,
17 
 404   Doxepin   Doxepin   D00814, D07875   3件: HRH1, SLC6A2, SLC6A4   5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle   1件:
6 
 405   Doxepin and zopiclone   Zopiclone   D01372   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
6 
 406   Dpa-714-pet/mri   -   -   -   -   1件:
6 
 407   Droxidopa   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
5,
6,
17 
 408   Duloxetine   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
6,
13 
 409   Duloxetine hydrochloride   Duloxetine   D01179, D07880   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
6 
 410   Duodopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 411   Duodopa intestinal gel   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 412   Duodopa ld/cd 20/5 mg/ml   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   1件:
6 
 413   Dynacirc cr (isradipine)   Isradipine   D00349   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
6 
 414   E2007   -   -   -   -   2件:
6,
144 
 415   Ebixa   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
6,
13 
 416   Ebixa®   -   -   -   -   1件:
6 
 417   Egcg   Epigallocatechin gallate   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299 
 418   Elc200   -   -   -   -   1件:
6 
 419   Eliprodil   Eliprodil   -   -   -   1件:
6 
 420   Eltoprazine   Eltoprazine   -   -   -   1件:
6 
 421   Eltoprazine hcl   Eltoprazine   -   -   -   1件:
6 
 422   Eltoprazine hydrochloride   Eltoprazine   -   -   -   1件:
6 
 423   Emd 128130   -   -   -   -   2件:
6,
156 
 424   Emd128130   -   -   -   -   1件:
6 
 425   Ent-01   -   -   -   -   1件:
6 
 426   Entacapon   -   -   -   -   1件:
6 
 427   Entacapona   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 428   Entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   2件:
6,
17 
 429   Entacapone and carbidopa   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   1件:
6 
 430   Epi-589   -   -   -   -   2件:
2,
6 
 431   Epi-743 200mg   -   -   -   -   1件:
6 
 432   Epi-743 400mg   -   -   -   -   1件:
6 
 433   Er cd-ld   -   -   -   -   1件:
6 
 434   Er tablet 100 mg azd3241   -   -   -   -   1件:
6 
 435   Er tablet 25 mg azd3241   -   -   -   -   1件:
6 
 436   Eradication of helcobacter pylori   -   -   -   -   1件:
6 
 437   Eradication therapy for h.pylori infection   -   -   -   -   1件:
6 
 438   Eradication therapy for helicobacter pylori   -   -   -   -   1件:
6 
 439   Erythromycin   Erythromycin   D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054   -   -   5件:
6,
36,
164,
228,
291 
 440   Erythropoietin   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 441   Erythropoietin human recombinant (eporh)   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
6 
 442   Escitalopram   Escitalopram   D02567, D07704, D07913   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
2,
6,
13 
 443   Esomeprazole   Esomeprazole   D01984, D04056, D07917, D09339   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   6件:
6,
46,
86,
98,
298,
299 
 444   Eszopiclone   Eszopiclone   D02624   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   3件:
6,
13,
46 
 445   Ethnodyne visio   -   -   -   -   1件:
6 
 446   Exametazime   Exametazime   D01109   -   -   1件:
6 
 447   Exelon   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   2件:
6,
13 
 448   Exelon 4.6 mg/24 h transdermal patch   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 449   Exelon 9.5 mg/24 h transdermal patch   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 450   Exelon patch (rivastigmine transdermal system)   Rivastigmine   D02558, D03822   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   1件:
6 
 451   Exenatide   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
193,
233 
 452   Exenatide 10 micrograms   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 453   Exenatide 5 micrograms   Exenatide   D04121   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
6 
 454   F-18 fpcit   -   -   -   -   1件:
6 
 455   Famotidine   Famotidine   D00318   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   3件:
6,
46,
86 
 456   Febuxostat   Febuxostat   D01206   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   3件:
2,
6,
13 
 457   Ferrprox (deferiprone)   Deferiprone   D07416   -   -   1件:
6 
 458   Fesoterodine   Fesoterodine   D07226   2件: CHRM2, CHRM3   11件: Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   1件:
6 
 459   Fetal porcine cells, neurocell-pd   -   -   -   -   1件:
6 
 460   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 461   Finasteride   Finasteride   D00321   1件: SRD5A2   2件: Prostate cancer, Steroid hormone biosynthesis   1件:
6 
 462   Fipamezole   Fipamezole   -   -   -   2件:
6,
17 
 463   Fipamezole hydrochloride   Fipamezole   -   -   -   2件:
6,
17 
 464   Fipamezole hydrochloride 30 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 465   Fipamezole hydrochloride 60 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 466   Fipamezole hydrochloride 90 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 467   Fipamezole odt   Fipamezole   -   -   -   1件:
6 
 468   Fipamezole odt cohort 2   Fipamezole   -   -   -   1件:
6 
 469   Flecainide   Flecainide   D00638, D07962   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 470   Flecainide acetate   Flecainide   D00638, D07962   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 471   Flecainidum   Flecainide   D00638, D07962   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   1件:
6 
 472   Florbetaben (18f)   -   -   -   -   1件:
6 
 473   Florbetapir f 18   -   -   -   -   1件:
6 
 474   Fludrocortisone   Fludrocortisone   D00986, D07967   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   3件:
6,
17,
81 
 475   Flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   5件:
6,
13,
17,
18,
206 
 476   Flutemetamol   Flutemetamol   -   -   -   5件:
5,
6,
7,
17,
127 
 477   Folic acid   Folic acid   D00070   -   -   4件:
6,
46,
49,
84 
 478   Folic acid, vitamin b6, vitamin b12   Folic acid   D00070   -   -   1件:
6 
 479   Foliglurax   Foliglurax   -   -   -   1件:
6 
 480   Fpf1100nw   -   -   -   -   1件:
6 
 481   Fpfs-1169   -   -   -   -   1件:
6 
 482   Fursultiamine   Fursultiamine   D03319   -   -   1件:
6 
 483   G-csf   Filgrastim   D03235   1件: